GlassScriptPhysician profile
Haroon Kamran
NPI 1083971816
$19,759.16
in general payments reported to CMS, 2019-2025
19 companies · $770 in 2025
The $770 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,707 · 2020: $5,130 · 2021: $3,095 · 2022: $3,456 · 2023: $2,894 · 2024: $707 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,624 · Travel and Lodging: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,624.35 |
| Travel and Lodging | $746.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,981.76 | 2019-2023 | Perclose Prostyle, Supera, Perclose Proglide |
| Medtronic, INC. | $2,967.58 | 2021-2025 | Turbohawk, Silverhawk, Symplicity G3 |
| Shockwave Medical, INC | $1,716.70 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $1,071.93 | 2019-2020 | |
| Boston Scientific Corporation | $899.48 | 2019-2025 | Eluvia, Rotapro, Avvigo Guidance System |
| Cardiovascular Systems INC. | $675.24 | 2019-2021 | |
| Abiomed | $363.67 | 2019-2025 | |
| Philips North America LLC | $345.91 | 2019-2024 | (5028) Igt Devices Systems Undivided |
| Janssen Pharmaceuticals, INC | $168.17 | 2020-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $142.39 | 2019-2020 | |
| Cardiva Medical, INC. | $83.67 | 2020 | |
| Chiesi USA, INC. | $72.18 | 2020 | |
| Heartflow, INC. | $60.79 | 2019 | |
| Edwards Lifesciences Corporation | $52.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $41.26 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.04 | 2020 | |
| Terumo Medical Corporation | $26.93 | 2020 | |
| Pfizer INC. | $26.21 | 2020 | |
| Alnylam Pharmaceuticals INC. | $22.59 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haroon Kamran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.